Squadron Capital Management LLC
Filing Date
Global Rank
#3,580
/ 8,623
▲ 438
· as of Mar 2026
Top Industry
Biotechnology
97.1%
3Y Alpha vs SPY
-1.9%
Period ended 4 months ago
Filed May 15, 2026 · 3mo
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+13.1%
SPY
+9.0%
Annualised alpha
+10.4%
Max drawdown
−19.1%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 93% of reported value on average across 2 quarters. Past performance does not predict future results.
Portfolio Concentration
33 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
21.6%
+7.7 pts
Top 5
52.9%
+5.0 pts
Top 10
69.9%
+3.2 pts
HHI
851
Diversified+208
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $272,919,020 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RLMD | Relmada Therapeutics, Inc. | +1,774,571 | 8,474,571 | $58,983,014 | |
| KALV | KalVista Pharmaceuticals, Inc. | +600,100 | 1,300,100 | $26,171,013 | |
| IVA | Inventiva S.A. | +235,000 | 535,000 | $2,969,250 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | +180,000 | 680,000 | $4,923,200 | |
| KOD | Kodiak Sciences Inc. | +88,290 | 380,000 | $14,485,600 | |
| NXTC | NextCure, Inc. | +28,034 | 265,000 | $2,830,200 | |
| GHRS | GH Research PLC | +10,000 | 325,000 | $4,569,500 | |
| COGT | Cogent Biosciences, Inc. | +7,492 | 787,492 | $30,310,567 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
8 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PALI | Palisade Bio, Inc. | −1,500,000 | 3,000,000 | $5,250,000 | |
| IKT | Inhibikase Therapeutics, Inc. | −725,000 | 3,500,000 | $5,880,000 | |
| MAZE | Maze Therapeutics, Inc. | −232,500 | 257,500 | $7,686,375 | |
| AVBP | ArriVent BioPharma, Inc. | −228,000 | 110,000 | $2,537,700 | |
| TRAW | Traws Pharma, Inc. | −201,826 | 511,714 | $936,436 | |
| LPCN | Lipocine Inc. | −80,000 | 450,000 | $3,595,500 | |
| SPRB | Spruce Biosciences, Inc. | −57,800 | 12,200 | $797,270 | |
| ABVX | Abivax S.A. | −15,000 | 130,000 | $14,475,500 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
15 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | 4,031,000 | $9,432,540 | |
| NKTR | Nektar Therapeutics | 125,000 | $8,993,750 | |
| ANL | Adlai Nortye Ltd. | 1,265,231 | $8,755,398 | |
| RLAY | Relay Therapeutics, Inc. | 822,500 | $8,183,875 | |
| IDYA | IDEAYA Biosciences, Inc. | 224,300 | $7,473,676 | |
| SCYX | Scynexis Inc | 7,608,695 | $6,977,173 | |
| CCCC | C4 Therapeutics, Inc. | 2,250,000 | $5,917,500 | |
| KPTI | Karyopharm Therapeutics Inc. | 750,000 | $4,177,500 | |
| PMN | ProMIS Neurosciences Inc. | 324,977 | $4,127,207 | |
| ALXO | Alx Oncology Holdings Inc | 1,460,000 | $2,927,300 | |
| CNTX | Context Therapeutics Inc. | 1,100,000 | $2,882,000 | |
| SLGL | Sol-Gel Technologies Ltd. | 31,000 | $2,455,820 | |
| TXMD | TherapeuticsMD, Inc. | 420,421 | $849,250 | |
| HOWL | Werewolf Therapeutics, Inc. | 563,535 | $469,424 | |
| NEUP | Neuphoria Therapeutics Inc. | 76,728 | $312,282 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
14 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | 190,000 | $7,676,000 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 80,000 | $6,550,400 | |
| UPB | Upstream Bio, Inc. | 230,650 | $6,262,147 | |
| XENE | Xenon Pharmaceuticals Inc. | 105,551 | $4,730,795 | |
| DBVT | DBV Technologies S.A. | 240,000 | $4,600,800 | |
| HELP | Cybin Inc. | 525,000 | $4,294,500 | |
| BLTE | Belite Bio, Inc | 26,000 | $4,158,960 | |
| VERA | Vera Therapeutics, Inc. | 60,000 | $3,038,400 | |
| WVE | Wave Life Sciences Ltd. | 175,000 | $2,975,000 | |
| CMPS | COMPASS Pathways plc | 388,287 | $2,679,180 | |
| AVTX | Avalo Therapeutics, Inc. | 130,000 | $2,360,800 | |
| ZBIO | Zenas BioPharma, Inc. | 36,000 | $1,307,160 | |
| NTLA | Intellia Therapeutics, Inc. | 81,000 | $728,190 | |
| CLYM | Climb Bio, Inc. | 100,000 | $400,000 | |
| No positions match the current search. | ||||
33 tracked positions ·
$272,919,020 total
· filing declares
37 positions · $272,917,617
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
Added | 8,474,571 | $58,983,014 | 21.61% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 787,492 | $30,310,567 | 11.11% | |
| KALV |
KalVista Pharmaceuticals, Inc.
CALL
+ SHARES
Healthcare
|
Added | 1,300,100 | $26,171,013 | 9.59% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Added | 380,000 | $14,485,600 | 5.31% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 130,000 | $14,475,500 | 5.30% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 350,000 | $11,025,000 | 4.04% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 4,031,000 | $9,432,540 | 3.46% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
NEW | 125,000 | $8,993,750 | 3.30% | |
| ANL |
Adlai Nortye Ltd.
Healthcare
|
NEW | 1,265,231 | $8,755,398 | 3.21% | |
| RLAY |
Relay Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 822,500 | $8,183,875 | 3.00% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Reduced | 257,500 | $7,686,375 | 2.82% | |
| IDYA |
IDEAYA Biosciences, Inc.
PUT
CALL
Healthcare
|
NEW | 224,300 | $7,473,676 | 2.74% | |
| SCYX |
Scynexis Inc
Healthcare
|
NEW | 7,608,695 | $6,977,173 | 2.56% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
NEW | 2,250,000 | $5,917,500 | 2.17% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Reduced | 3,500,000 | $5,880,000 | 2.15% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Reduced | 3,000,000 | $5,250,000 | 1.92% | |
| EPRX |
Eupraxia Pharmaceuticals Inc.
Healthcare
|
Added | 680,000 | $4,923,200 | 1.80% | |
| GHRS |
GH Research PLC
Healthcare
|
Added | 325,000 | $4,569,500 | 1.67% | |
| KPTI |
Karyopharm Therapeutics Inc.
PUT
Healthcare
|
NEW | 750,000 | $4,177,500 | 1.53% | |
| PMN |
ProMIS Neurosciences Inc.
Healthcare
|
NEW | 324,977 | $4,127,207 | 1.51% | |
| LPCN |
Lipocine Inc.
Healthcare
|
Reduced | 450,000 | $3,595,500 | 1.32% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 535,000 | $2,969,250 | 1.09% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
NEW | 1,460,000 | $2,927,300 | 1.07% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
NEW | 1,100,000 | $2,882,000 | 1.06% | |
| NXTC |
NextCure, Inc.
Healthcare
|
Added | 265,000 | $2,830,200 | 1.04% | |
| AVBP |
ArriVent BioPharma, Inc.
CALL
Healthcare
|
Reduced | 110,000 | $2,537,700 | 0.93% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
NEW | 31,000 | $2,455,820 | 0.90% | |
| KTTA |
Pasithea Therapeutics Corp.
Healthcare
|
Held | 2,100,000 | $1,558,200 | 0.57% | |
| TRAW |
Traws Pharma, Inc.
Healthcare
|
Reduced | 511,714 | $936,436 | 0.34% | |
| TXMD |
TherapeuticsMD, Inc.
Healthcare
|
NEW | 420,421 | $849,250 | 0.31% | |
| SPRB |
Spruce Biosciences, Inc.
Healthcare
|
Reduced | 12,200 | $797,270 | 0.29% | |
| HOWL |
Werewolf Therapeutics, Inc.
Healthcare
|
NEW | 563,535 | $469,424 | 0.17% | |
| NEUP |
Neuphoria Therapeutics Inc.
Healthcare
|
NEW | 76,728 | $312,282 | 0.11% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.